Carol Mason, MD, FCCP

Cabiran Professor of Medicine & Section Chief
Medical Director of Respiratory Therapy, MCLNO
Staff Physician, MCLNO, Ochsner

LSU Healthcare Network Clinic
200 West Esplanade, Suite 701
Kenner, LA 70065
Phone: (504) 412-1705
Fax: (504) 412-1702

Request an Appointment

 

Academic Office

LSU Health Sciences Center
Pulmonary/Critical Care & Allergy/Immunology
1901 Perdido Street, Suite 3205
New Orleans, LA 70112
Phone: (504) 568-4634
Fax: (504) 568-4295
mason@lsuhsc.edu

Degrees

MD - 1982
Louisiana State University School of Medicine - New Orleans

Bio

Carol Mason, M.D. is a graduate of LSU Medical School in New Orleans, LA.  She completed Internal Medicine residency training at Charity Hospital in New Orleans  (LSU Division), and Pulmonary/Critical Care Medicine fellowship training at the University of Texas Southwestern Medical School in Dallas, Texas.  She is currently the Louis R. Cabiran Professor and Acting Chief of the Section of Pulmonary/Critical Care Medicine at LSU Medical School.  She serves as the Medical Director of Respiratory Therapy at the Interim LSU Hospital (formerly Charity Hospital).  Dr. Mason is a basic research investigator, examining the role of alcohol consumption on pulmonary tuberculosis in a murine model, and is collaborating in translational research to correlate human and nonhuman primate latent and active TB infection.  Other interests include pulmonary infections, and the burgeoning problem of antimicrobial resistance, as well as tobacco abuse and smoking cessation.

Research Interests General Pulmonary Diseases
Mechanisms of pulmonary host defense against infections
Committees & Administrative Responsibilities

LSUHSC SOM Committee on Professional Conduct
LSUHSC School of Medicine Appointments and Promotions Committee
Department of Medicine's Vice Chair for Academic Affairs

Selected Publications

Porretta E, Happel KI, Teng XS, Ramsay A, Mason CM.  The impact of alcohol on BCG-induced immunity against Mycobacterium tuberculosis. Alc Clin Exp Res 36:310-317, 2012

Ramirez J, Mason C, Ali J. Case of the Month: Mycobacterium avium complex pulmonary disease: management options in HIV-negative patients. Journal of the Louisiana State Medical Society, 160:248-254, 2008.

Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, Reinhart TA, McAllister F, Edeal J, Gaus K, Husain S, Kreindler JL, Dubin PJ, Pilewski JM, Myerburg MM, Mason CM, Iwakura Y, Kolls JK. IL-22 mediates mucosal host defense against gram negative bacterial pneumonia. Nat Med 14:275-281, 2008 (advance online, doi:10.1038/nm1710).

Ramirez J, Mason C, Ali J. Use of mefloquine in multi-drug resistant Mycobacterium avium complex pulmonary disease in an HIV-negative patient. Curr Ther Res 68:421-429, 2007.

Mason C, Porretta E, Zhang P, Nelson S. CD4+CD25+TGF--producing T cells are present in the lung in murine tuberculosis and may regulate the host inflammatory response. Clin Exp Immunol 148:537-545, 2007. (doi: 10.1111/j.1365-2249.2007.03371.x)

Zea AH, Culotta K, Ali J, Mason C, Park H, Zabeleta J, Garcia LF, Ochoa AC. Decreased expression of CD3 and NF-B in patients with pulmonary tuberculosis (PTB): potential mechanisms and reversibility with treatment. J Infect Dis 194:1385-1393, 2006.

Zhang P, Mason CM, Nelson S. Phagocytes in the pulmonary host defense system. In: Respiratory Infections, Torres A, Ewig S, Mandell L, and Woodhead M, eds. Hodder Arnold Publishers, London, 2006; pp 19-29.

Seoane L and Mason CM. Parenchymal Lung Disease. In: Pulmonary Pathophysiology, 2nd ed. Ali J, Levitzky MG, and Summer WR, eds. McGraw-Hill, New York, 2005; pp 105-125.

Happel KI, Lockhart E, Mason CM, Porretta E, Keoshkerian E, Odden AR, Nelson S, Ramsay AJ. Pulmonary IL-23 gene delivery increases local T cell immunity and controls growth of Mycobacterium tuberculosis in the lungs. Infect Immun 73:5782, 2005.

Badewa AP, Quinton LJ, Shellito JE, and Mason CM. Chemokine receptor 5 and its ligands in the immune response to murine tuberculosis. Tuberculosis 85:185-195, 2005.